Tumor necrosis factor-alpha inhibition protects against endotoxin-induced endothelial glycocalyx perturbation.

[1]  J. Kastelein,et al.  Measuring endothelial glycocalyx dimensions in humans: a potential novel tool to monitor vascular vulnerability , 2011 .

[2]  D. Hommes,et al.  Enhanced atherogenesis and altered high density lipoprotein in patients with Crohn's disease Published, JLR Papers in Press, September 22, 2007. , 2007, Journal of Lipid Research.

[3]  J. Romijn,et al.  Apolipoprotein C-I Is Crucially Involved in Lipopolysaccharide-Induced Atherosclerosis Development in Apolipoprotein E-Knockout Mice , 2007, Circulation.

[4]  J. Vincent,et al.  Microvascular response to red blood cell transfusion in patients with severe sepsis* , 2007, Critical care medicine.

[5]  P. Cabrales,et al.  Microvascular and capillary perfusion following glycocalyx degradation. , 2007, Journal of applied physiology.

[6]  T. van der Poll,et al.  High-Density Lipoprotein Attenuates Inflammation and Coagulation Response on Endotoxin Challenge in Humans , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[7]  J. Kastelein,et al.  Effects of CRP infusion on endothelial function and coagulation in normocholesterolemic and hypercholesterolemic subjects Published, JLR Papers in Press, January 26, 2007. , 2007, Journal of Lipid Research.

[8]  J. Romijn,et al.  Apolipoprotein CI Is Crucially Involved in Lipopolysaccharide-Induced Atherosclerosis Development in Apolipoprotein E – Knockout Mice , 2007 .

[9]  B. Duling,et al.  Reactive oxygen species mediate modification of glycocalyx during ischemia-reperfusion injury. , 2006, American journal of physiology. Heart and circulatory physiology.

[10]  S. Weinbaum,et al.  Large-deformation analysis of the elastic recoil of fibre layers in a Brinkman medium with application to the endothelial glycocalyx , 2006, Journal of Fluid Mechanics.

[11]  L. Bernstein,et al.  Effects of etanercept in patients with the metabolic syndrome. , 2006, Archives of internal medicine.

[12]  R. Heine,et al.  Endothelial glycocalyx damage coincides with microalbuminuria in type 1 diabetes. , 2006, Diabetes.

[13]  J. Kastelein,et al.  Loss of endothelial glycocalyx during acute hyperglycemia coincides with endothelial dysfunction and coagulation activation in vivo. , 2006, Diabetes.

[14]  C. Esmon.  The interactions between inflammation and coagulation , 2005, British journal of haematology.

[15]  Hans Vink,et al.  The endothelial glycocalyx: a potential barrier between health and vascular disease , 2005, Current opinion in lipidology.

[16]  E. Czarnowska,et al.  Superoxide- and nitric oxide-derived species mediate endothelial dysfunction, endothelial glycocalyx disruption, and enhanced neutrophil adhesion in the post-ischemic guinea-pig heart. , 2005, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[17]  M. Wolzt,et al.  Simvastatin Blunts Endotoxin-Induced Tissue Factor In Vivo , 2005, Circulation.

[18]  Gerene M Denning,et al.  Potential role of endotoxin as a proinflammatory mediator of atherosclerosis. , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[19]  Sheldon Weinbaum,et al.  The role of the glycocalyx in reorganization of the actin cytoskeleton under fluid shear stress: a "bumper-car" model. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[20]  A. Mulivor,et al.  Inflammation- and ischemia-induced shedding of venular glycocalyx. , 2004, American journal of physiology. Heart and circulatory physiology.

[21]  J. Schwartz,et al.  Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. , 2003, The New England journal of medicine.

[22]  J. Spaan,et al.  Endothelial Cell Glycocalyx Modulates Immobilization of Leukocytes at the Endothelial Surface , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[23]  Stephen C. Cowin,et al.  Mechanotransduction and flow across the endothelial glycocalyx , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Hans Vink,et al.  The Endothelial Glycocalyx Protects Against Myocardial Edema , 2003, Circulation research.

[25]  JoAnn E. Manson,et al.  Cardiovascular Morbidity and Mortality in Women Diagnosed With Rheumatoid Arthritis , 2003, Circulation.

[26]  P. Libby.  Inflammation in atherosclerosis , 2002, Nature.

[27]  A. Mulivor,et al.  Role of glycocalyx in leukocyte-endothelial cell adhesion. , 2002, American journal of physiology. Heart and circulatory physiology.

[28]  M. Wolzt,et al.  High Doses of Vitamin C Reverse Escherichia coli Endotoxin–Induced Hyporeactivity to Acetylcholine in the Human Forearm , 2002, Circulation.

[29]  R. Stern,et al.  Inhibitors of the hyaluronidases. , 2002, Matrix biology : journal of the International Society for Matrix Biology.

[30]  B. Duling,et al.  TNF-α increases entry of macromolecules into luminal endothelial cell glycocalyx , 2000 .

[31]  Långström,et al.  [11C]Hyaluronan uptake with positron emission tomography in liver disease , 2000, European journal of clinical investigation.

[32]  Aroon D. Hingorani,et al.  Acute Systemic Inflammation Impairs Endothelium-Dependent Dilatation in Humans , 1999, Circulation.

[33]  B. Duling,et al.  TNF-alpha increases entry of macromolecules into luminal endothelial cell glycocalyx. , 2000, American journal of physiology. Heart and circulatory physiology.

[34]  K. Messmer,et al.  Orthogonal polarization spectral imaging: A new method for study of the microcirculation , 1999, Nature Medicine.

[35]  B. Duling,et al.  Permeation of the luminal capillary glycocalyx is determined by hyaluronan. , 1999, American journal of physiology. Heart and circulatory physiology.

[36]  H. D. Hochstein,et al.  Dose-related inflammatory effects of intravenous endotoxin in humans: evaluation of a new clinical lot of Escherichia coli O:113 endotoxin. , 1999, The Journal of infectious diseases.

[37]  M. Mohamadzadeh,et al.  Proinflammatory stimuli regulate endothelial hyaluronan expression and CD44/HA-dependent primary adhesion. , 1998, The Journal of clinical investigation.

[38]  R. Stern,et al.  A microtiter-based assay for hyaluronidase activity not requiring specialized reagents. , 1997, Analytical biochemistry.

[39]  S. Berg.  Hyaluronan turnover in relation to infection and sepsis , 1997, Journal of internal medicine.

[40]  T. van der Poll,et al.  Effect of a recombinant dimeric tumor necrosis factor receptor on inflammatory responses to intravenous endotoxin in normal humans. , 1997, Blood.

[41]  B. Duling,et al.  Identification of distinct luminal domains for macromolecules, erythrocytes, and leukocytes within mammalian capillaries. , 1996, Circulation research.

[42]  R. Heyderman,et al.  Alteration in glycosaminoglycan metabolism and surface charge on human umbilical vein endothelial cells induced by cytokines, endotoxin and neutrophils. , 1992, Journal of cell science.